Question 1

What is N-Acetyl Selank Amidate?

Accepted Answer

Acetylated and C-terminally amidated derivative of Selank, a synthetic heptapeptide based on the endogenous immunomodulatory tetrapeptide tuftsin (Thr-Lys-Pro-Arg) extended with a Pro-Gly-Pro stabilizing tail. The N-terminal acetyl and C-terminal amide groups are intended to increase resistance to peptidases and improve stability versus unmodified Selank. Proposed anxiolytic mechanisms include modulation of GABAergic and serotonergic signaling and altered expression of BDNF and inflammatory cytokines. It is not FDA-approved; Selank is registered as an anxiolytic only in Russia, and the acetyl-amidate variant is a grey-market research compound without controlled human efficacy data. Merit Verified tracks independent COA test results for N-Acetyl Selank Amidate from multiple vendors.

Question 2

Which vendors sell N-Acetyl Selank Amidate with independent COA testing?

Accepted Answer

7 vendors in the Merit Verified directory have independent COA evidence on file for N-Acetyl Selank Amidate — 16 COAs total. COA coverage and test dates are listed on the N-Acetyl Selank Amidate page at https://meritverified.org/peptides/n-acetyl-selank-amidate.

Question 3

How do I verify the quality of N-Acetyl Selank Amidate from a vendor?

Accepted Answer

To verify N-Acetyl Selank Amidate quality, look for an independent certificate of analysis (COA) from a third-party lab — not a lab the vendor owns or pays directly. The COA should state the tested compound, lot number, purity percentage (identity and concentration), and the lab's name. Cross-reference the lot number against the vendor's current stock. Merit Verified indexes COAs for N-Acetyl Selank Amidate at https://meritverified.org/peptides/n-acetyl-selank-amidate so you can compare evidence across vendors before buying.

Question 4

What is the regulatory status of N-Acetyl Selank Amidate?

Accepted Answer

N-Acetyl Selank Amidate is classified as research-use only in the Merit Verified registry. In the United States, the FDA removed several peptides including BPC-157, TB-500, and GLP-1 analogues from the 503A compounding ingredient list in April 2026, restricting their use in compounded drugs for human administration. Vendors selling N-Acetyl Selank Amidate for research purposes are not selling it as a drug or supplement; the legal status of purchasing for personal use varies by jurisdiction. Merit Verified does not provide legal or medical advice — confirm current regulatory status with a licensed professional.

N-Acetyl Selank Amidate

Pricing for N-Acetyl Selank Amidate

COAs for N-Acetyl Selank Amidate